These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

790 related articles for article (PubMed ID: 19230736)

  • 1. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
    Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
    Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cell therapy for diabetes through paracrine mechanisms.
    Xu YX; Chen L; Wang R; Hou WK; Lin P; Sun L; Sun Y; Dong QY
    Med Hypotheses; 2008 Sep; 71(3):390-3. PubMed ID: 18538944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of insulin-producing beta cells from stem cells--perspectives for cell therapy in type 1 diabetes.
    Seissler J; Schott M
    Horm Metab Res; 2008 Feb; 40(2):155-61. PubMed ID: 18283634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus.
    Limbert C; Päth G; Jakob F; Seufert J
    Diabetes Res Clin Pract; 2008 Mar; 79(3):389-99. PubMed ID: 17854943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of insulin-producing cells from stem cells for cell replacement therapy of type 1 diabetes.
    Efrat S
    Isr Med Assoc J; 2004 May; 6(5):265-7. PubMed ID: 15151363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus.
    Zhang H; Zeng X; Sun L
    Expert Opin Biol Ther; 2010 May; 10(5):701-9. PubMed ID: 20345339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of embryonic and adult stem cells into insulin producing cells.
    Zulewski H
    Panminerva Med; 2008 Mar; 50(1):73-9. PubMed ID: 18427390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell-based approaches to solving the problem of tissue supply for islet transplantation in type 1 diabetes.
    Street CN; Sipione S; Helms L; Binette T; Rajotte RV; Bleackley RC; Korbutt GS
    Int J Biochem Cell Biol; 2004 Apr; 36(4):667-83. PubMed ID: 15010331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes.
    Urbán VS; Kiss J; Kovács J; Gócza E; Vas V; Monostori E; Uher F
    Stem Cells; 2008 Jan; 26(1):244-53. PubMed ID: 17932424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease.
    McTaggart SJ; Atkinson K
    Nephrology (Carlton); 2007 Feb; 12(1):44-52. PubMed ID: 17295660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
    Reinders ME; Fibbe WE; Rabelink TJ
    Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antidiabetic effect of mesenchymal stem cells is unrelated to their transdifferentiation potential but to their capability to restore Th1/Th2 balance and to modify the pancreatic microenvironment.
    Ezquer F; Ezquer M; Contador D; Ricca M; Simon V; Conget P
    Stem Cells; 2012 Aug; 30(8):1664-74. PubMed ID: 22644660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
    Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-cell replacement for insulin-dependent diabetes mellitus.
    Efrat S
    Adv Drug Deliv Rev; 2008 Jan; 60(2):114-23. PubMed ID: 18022276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells adopt beta-cell fate upon diabetic pancreatic microenvironment.
    Chang C; Wang X; Niu D; Zhang Z; Zhao H; Gong F
    Pancreas; 2009 Apr; 38(3):275-81. PubMed ID: 19066494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
    Jones BJ; McTaggart SJ
    Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current status and perspectives of stem cell therapy for the treatment of diabetes mellitus].
    Päth G; Seufert J
    Med Klin (Munich); 2003 Apr; 98(5):277-82. PubMed ID: 12721673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multipotent mesenchymal stromal cells in articular diseases.
    Jorgensen C; Djouad F; Bouffi C; Mrugala D; Noël D
    Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):269-84. PubMed ID: 18455684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel beta-cell specific promoter system for the identification of insulin-producing cells in in vitro cell cultures.
    Fukazawa T; Matsuoka J; Naomoto Y; Nakai T; Durbin ML; Kojima I; Lakey JR; Tanaka N
    Exp Cell Res; 2006 Oct; 312(17):3404-12. PubMed ID: 16934249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin and pellet suspension culture promote differentiation of human mesenchymal stem cells into insulin producing cells.
    Chang CF; Hsu KH; Chiou SH; Ho LL; Fu YS; Hung SC
    J Biomed Mater Res A; 2008 Sep; 86(4):1097-105. PubMed ID: 18080299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.